Research programme: macrophage-1-antigen modulators - Sujana Biotech
Alternative Names: Mac-1:GPIb alpha inhibitors - Sujana Biotech; Macrophage-1-antigen modulators - Sujana BiotechLatest Information Update: 28 Oct 2021
Price :
$50 *
At a glance
- Originator Sujana Biotech
- Class Anti-inflammatories; Monoclonal antibodies; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants; Macrophage 1 antigen modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Inflammation; Vascular disorders
Most Recent Events
- 28 Oct 2021 No recent reports of development identified for preclinical development in Inflammation in USA (Parenteral)
- 28 Oct 2021 No recent reports of development identified for preclinical development in Vascular-disorders in USA (Parenteral)
- 01 Nov 2017 Macrophage-1-antigen modulators - Sujana Biotech is available for licensing as of 01 Nov 2017. http://www.sujanabio.com/partners/